These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27918099)

  • 21. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis.
    Wang YH; Wu WJ; Wang WJ; Huang HY; Li WM; Yeh BW; Wu TF; Shiue YL; Sheu JJ; Wang JM; Li CF
    Oncotarget; 2015 Oct; 6(31):31069-84. PubMed ID: 26307680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1.
    Gu H; Yang T; Fu S; Chen X; Guo L; Ni Y
    Biochem Biophys Res Commun; 2014 Jan; 444(1):104-8. PubMed ID: 24440705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression.
    Chan TC; Hsing CH; Shiue YL; Huang SK; Hsieh KL; Kuo YH; Li CF
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-23b-3p and miR-125b-5p downregulate apo(a) expression by targeting Ets1 in HepG2 cells.
    Zeng JF; Zeng ZL; Zhang K; Zhao Y; Liu YM; Chen JJ; Tong H; Wei DH; Jiang ZS; Wang Z
    Cell Biol Int; 2018 Mar; 42(3):313-323. PubMed ID: 29064597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b.
    Yang H; Liu P; Zhang J; Peng X; Lu Z; Yu S; Meng Y; Tong WM; Chen J
    Oncogene; 2016 Jul; 35(28):3647-57. PubMed ID: 26549028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-193b-3p Regulates TLR4 Expression to Inhibit Inflammation by Targeting ETS1 in Allergic Rhinitis.
    Jing Y; Xie J; Huang M; Zhao W; Long S; Zhao S
    Int Arch Allergy Immunol; 2023; 184(8):727-735. PubMed ID: 37231959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression.
    Zheng F; Wang M; Li Y; Huang C; Tao D; Xie F; Zhang H; Sun J; Zhang C; Gu C; Wang Z; Jiang G
    Cancer Lett; 2019 Sep; 460():139-151. PubMed ID: 31255724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additive effect of metastamiR-193b and breast cancer metastasis suppressor 1 as an anti-metastatic strategy.
    Hashemi ZS; Forouzandeh Moghadam M; Khalili S; Ghavami M; Salimi F; Sadroddiny E
    Breast Cancer; 2019 Mar; 26(2):215-228. PubMed ID: 30284194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth.
    Xiang W; Wu X; Huang C; Wang M; Zhao X; Luo G; Li Y; Jiang G; Xiao X; Zeng F
    Oncotarget; 2017 Jan; 8(1):664-678. PubMed ID: 27893422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-193b-3p possesses anti-tumor activity in ovarian carcinoma cells by targeting p21-activated kinase 3.
    Zhang J; Qin J; Su Y
    Biomed Pharmacother; 2017 Dec; 96():1275-1282. PubMed ID: 29169729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
    Chang W; Wang Y; Li W; Shi L; Geng Z
    J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-324-5p/PTPRD/CEBPD axis promotes papillary thyroid carcinoma progression via microenvironment alteration.
    Yang Y; Xia S; Zhang L; Wang W; Chen L; Zhan W
    Cancer Biol Ther; 2020 Jun; 21(6):522-532. PubMed ID: 32151175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling.
    Gu C; Cai J; Xu Z; Zhou S; Ye L; Yan Q; Zhang Y; Fang Y; Liu Y; Tu C; Wang X; He J; Li Q; Han L; Lin X; Li A; Liu S
    Cell Death Dis; 2019 Sep; 10(10):739. PubMed ID: 31570702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
    Hu J; Fang Y; Cao Y; Qin R; Chen Q
    Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer.
    Zhou Y; Liu F; Xu Q; Yang B; Li X; Jiang S; Hu L; Zhang X; Zhu L; Li Q; Zhu X; Shao H; Dai M; Shen Y; Ni B; Wang S; Zhang Z; Teng Y
    Oncogene; 2020 Aug; 39(34):5633-5648. PubMed ID: 32661323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-5195-3p Inhibits Proliferation and Invasion of Human Bladder Cancer Cells by Directly Targeting Oncogene KLF5.
    Jiang Z; Zhang Y; Cao R; Li L; Zhong K; Chen Q; Xiao J
    Oncol Res; 2017 Aug; 25(7):1081-1087. PubMed ID: 28109084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.
    Wang X; Zhu J
    Thorac Cancer; 2018 Jun; 9(6):676-683. PubMed ID: 29697201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.